CAS No.: 1350653-20-1
Vericiguat/维利西呱 Catalog No. CSN19707
Synonyms: BAY1021189;维利西呱
Vericiguat targets soluble guanylate cyclase (sGC) and is used for treating heart failure.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01951638 Heart Failure Phase 2 Completed - - NCT01951625 Heart Failure Phase 2 Completed - - NCT02861534 Heart Failure ... more >> Chronic Heart Failure With Reduced Ejection Fraction Collapse << Phase 3 Recruiting January 24, 2020 - - 更多
- 参考文献
- [1] Pieske B, Maggioni AP, et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF(SOCRATES-PRESERVED) study. Eur Heart J. 2017 Mar 22.
- [2] Gheorghiade M, Greene SJ, et al. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial. JAMA. 2015 Dec 1;314(21):2251-62.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1350653-20-1 | 储存条件 |
|
|
| 分子式 | C19H16F2N8O2 | 运输 | 蓝冰 | |
| 分子量 | 426.38 | 别名 | BAY1021189;维利西呱 |
